Coming Off Imatinib - Nic Puntis

Coming off Imatinib – Nic Puntis

No Differences in Molecular Relapse-Free Survival After Stopping Imatinib Treatment

Cancer Therapy Advisor

Dr. Pamela Crilley on Imatinib and Second Generation TKIs

Targeted Oncology

Starting first-line treatment, update on Imatinib.

CML Support Group UK

Dr. Jerald Radich on Impact of Generic Imatinib in CML

GIST Support UK - Welcome Address - Nic Puntis, October 2017, Cardiff

My experience taking Gleevec after 2 weeks

Faith Greater Than Cancer

Imatinib, where are we now? What about generic Imatinib? Dr Joanne Ewing

CML Support Group UK

Imatinib - a Targeted Therapy Drug used to Treat Cancer | FAQ English | Onco Cancer Care

GIST Cancer UK - Generic Imatinib : The Cambridge Experience, Dr. Ramesh Bulusu at London April 2023

What do you need to know about Imatinib® (Generic Gleevec)?

Ask Marley Drug

GIST Support UK - Welcome & Introduction to the GSUK Trustees - Nic Puntis, March 2017, Sheffield

Generic Imatinib: Gaining Perspective

The Life Raft Group

Serum Imatinib (Gleevec) Levels Predict GIST Response

New Horizons GIST 2020: Episode 4 - Metastatic (advanced) disease

Sarcoma Patient Advocacy Global Network SPAGN

What side effects do I need to know about and how can I manage them? Dr Dragana Milojkovic

CML Support Group UK

Straight Talk: 20 years of Gleevec, the life-saving cancer drug pioneered by an OHSU doctor

Managing the Side Effects of Treatments – Vicky Rockingham

The importance of better selecting patients with CML who are eligible for treatment discontinuation

VJHemOnc – Video Journal of Hematology & HemOnc